Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- Mice
Original Article|Updated:2024-09-23
|
Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- Mice
Chinese Journal of Integrative MedicineVol. 30, Issue 10, Pages: 896-905(2024)
Affiliations:
1.The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou (510405), China
2.Department of Cardiology, Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou (510020), China
3.Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou (510020), China
OU Xiao-min, CAI Jing, HU Xiao-yue, et al. Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- Mice. [J]. Chinese Journal of Integrative Medicine 30(10):896-905(2024)
DOI:
OU Xiao-min, CAI Jing, HU Xiao-yue, et al. Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- Mice. [J]. Chinese Journal of Integrative Medicine 30(10):896-905(2024) DOI: 10.1007/s11655-024-3663-2.
Treg Immunomodulation Contributes to the Anti-atherosclerotic Effects of Huxin Formula in ApoE-/- Mice
To explore the effects of Huxin formula (HXF) in curtailing atherosclerosis and its underlying mechanism.
Methods:
2
According to random number table method
24 specific pathogen free male ApoE
-/-
mice were randomly divided into model group
HXF low-dose (HXF-L) group (8.4 g/kg daily)
HXF high-dose (HXF-H) group (16.8 g/kg daily)
and pravastatin (8 mg/kg daily) group in Experiment Ⅰ (
n
=6 per group). C57BL/6J mice served as the control group (
n
=6). ApoE
-/-
mice in HXF-L
HXF-H
pravastatin groups were fed a Western diet and administered continuously by gavage for 12 weeks
while C57BL/6J mice in the control group were fed conventional lab mouse chow for 12 weeks. Further
Tregs were depleted by weekly intraperitoneal
injection of purified anti-mouse CD25 antibody (PC61
250 μg per mouse) for 4 weeks in Experiment Ⅱ (
n
=6 per group). Oil Red O and Masson staining were used to evaluate the plaque area and aortic root fibrosis. The CD4
+
CD25
+
Foxp3
+
Treg counts in the lymph nodes and spleen cells were detected using flow cytometric analysis. The transforming growth factor-β1 (TGF-β1)
interleukin (IL)-10
and IL-6 serum levels were examined by MILLIPLEX
®
MAP technology. Quantitative real-time reverse transcription PCR (qRT-PCR) and Western blot were utilized to assess the expression of TGF-β mRNA and protein in the aorta. The expression of CD4
+
T lymphocytes
macrophages and smooth muscle cells in the aortic root were detected by immunofluorescence staining.
Results:
2
HXF reduced plaque area in ApoE
-/-
mice (
P
<
0.01). HXF increased the Treg counts in the lymph nodes and spleen cells (
P
<
0.05 or
P
<
0.01). Moreover
HXF alleviated inflammatory response via elevating IL-10 and TGF-β1 serum levels (
P
<
0.05)
while decreasing the IL-6 serum levels in ApoE
-/-
mice (
P
>
0.05). Also
HXF upregulated the expression of TGF-β mRNA and protein in the aorta (
P
<
0.05). Additionally
HXF attenuated CD4
+
T lymphocytes
macrophages and smooth muscle cells in aortic root plaque (
P
<
0.01). Furthermore
the depletion of Tregs with CD25 antibody (PC61) curtailed the reduction in plaque area and aortic root fibrosis by HXF (
P
<
0.01).
Conclusion:
2
HXF relieved atherosclerosis
probably by restraining inflammatory response
reducing inflammatory cell infiltration and attenuating aortic root fibrosis by increasing Treg counts.